Iqvia Holdings (IQV) Net Cash Flow (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Net Cash Flow came in at -$37.0 million in Q2 2026, down 115.29% year-over-year from $242.0 million in Q2 2025, and down 236.36% quarter-over-quarter from -$11.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Net Cash Flow (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Net Cash Flow across 15 years of filings, most recently posting -$37.0 million for Q2 2026.
- In Q2 2026, Net Cash Flow fell 115.29% year-over-year to -$37.0 million; the TTM figure through Jun 2026 stood at -$96.0 million (down 122.22% YoY), while the FY2025 annual figure was $199.0 million, down 49.49% from the prior year.
- Net Cash Flow came in at -$37.0 million for Q2 2026 at Iqvia Holdings, down from -$11.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $282.0 million in Q1 2023 to a low of -$214.0 million in Q3 2025.
- Average Net Cash Flow over 5 years is $35.2 million, with a median of $22.0 million recorded in 2022.
- Year-over-year, Net Cash Flow jumped 623.08% in 2023 and tumbled 1326.67% in 2025.
- Over 5 years, Net Cash Flow stood at -$110.0 million in 2022, then jumped by 204.55% to $115.0 million in 2023, then surged by 73.91% to $200.0 million in 2024, then retreated by 17.0% to $166.0 million in 2025, then plunged by 122.29% to -$37.0 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$37.0 million in Q2 2026, -$11.0 million in Q1 2026, and $166.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -37.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -150.21 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 164.82 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 43.16 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 21.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.70 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -514,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.71 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -37.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | 166.00 Mn |
| Sep 30, 2025 | -214.00 Mn |
| Jun 30, 2025 | 242.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 200.00 Mn |
| Sep 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | 107.00 Mn |
| Mar 31, 2024 | 102.00 Mn |
| Dec 31, 2023 | 115.00 Mn |
| Sep 30, 2023 | -134.00 Mn |
| Jun 30, 2023 | -99.00 Mn |
| Mar 31, 2023 | 282.00 Mn |
| Dec 31, 2022 | -110.00 Mn |
| Sep 30, 2022 | -105.00 Mn |
| Jun 30, 2022 | 101.00 Mn |
| Mar 31, 2022 | 39.00 Mn |
| Dec 31, 2021 | -93.00 Mn |
| Sep 30, 2021 | -317.00 Mn |